Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse

ejd.2013.2143 Auteur(s) : Marie Tauber1 tauberma@gmail.com, Cecile Pages1, Roberta La Selva1, Pierre Schneider1, Jacques Chardin2, Amelie Osio3, Samia Mourah4, Stephane Culine5, Laetitia Vercellino4, Martine Bagot1, Celeste Lebbe1 1 APHP Dermatology unit, 2 APHP Stomatology unit, 3 APHP Pathology unit, 4 APHP Pharmacology Department, 5 APHP Oncology unit, Saint-Louis Hospital, Paris. 1 avenue Claude Vellefaux, 75010, Paris, France Vemurafenib is indicated alone in the treatment of unresectable or [...]